People · Operator
Named in public records as an officer, director or promoter · active 2013–2026 · Other Technology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Coinbase Global, Inc. | — | Other Technology | Series D+ | $416.4M | $673.6M | 2016 |
| Royal Markets, Inc. | — | Other Technology | Series C | $66.1M | $1.1B | 2021 |
| Coinbase Inc. | — | Other Technology | Series A | $6.1M | $169.5M | 2013 |
| Yuva Biosciences, Inc. | — | Biotech / Pharma | Series A | $5.6M | $2.6M | 2026 |
Fred Ehrsam at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Fred Ehrsam on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Armstrong | 2 | 8 |
| Keith Rabois | 1 | 25 |
| Fred Wilson | 1 | 15 |
| Barry Schuler | 1 | 9 |
| Asiff Hirji | 1 | 4 |
| Brian Brooks | 1 | 3 |
| Kathryn Haun | 1 | 2 |
| Greg Schmergel | 1 | 2 |
| Justin Ross | 1 | 2 |
| Jennifer Jones | 1 | 2 |
| Daniel Browne | 1 | 1 |
| Alesia Haas | 1 | 1 |
| Michael Lempres | 1 | 1 |
| Chris Dodds | 1 | 1 |
| Jeff Horowitz | 1 | 1 |
| Justin Blau | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.